1. Scrip
  2. >>Business
  3. >>Legal & IP

India Digital Personal Data Protection Norms: What It May Mean For Clinical Trials, Big Pharma GCCs

 
• By Anju Ghangurde

Legal heavyweights from Nishith Desai Associates, Anand and Anand, Corporate Law Group and EY partner and national cyber leader outline key compliance aspects that pharma and their global capability centers may need to factor as India moves to strengthen the framework for the protection of digital personal data.

Data protection
India bolsters framework to protect digital personal data (Shutterstock)

Pharma firms operating in India may need to make certain key modifications to their current data privacy programs, including adapting newer controls, to align with the country’s digital personal data protection norms, say legal experts.

India’s Ministry of Electronics and Information Technology (MeitY) had, earlier this month, released the draft Digital Personal Data Protection Rules, 2025 for public consultation. The draft rules, which are open...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Clinical Trials